Page last updated: 2024-08-17

visnagin and Cardiomyopathies

visnagin has been researched along with Cardiomyopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asnani, A; Bentley, VL; Berman, JN; Chao, W; Chen, HH; Dai, M; Dellaire, G; Haber, DA; Liu, Y; Peterson, RT; Sarkar, KS; Shin, JT; Sosnovik, DE; Wang, Y; Yu, M; Zou, L	1

Other Studies

1 other study(ies) available for visnagin and Cardiomyopathies

Article	Year
Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase. Science translational medicine, 2014, Dec-10, Volume: 6, Issue:266 Topics: Animals; Antineoplastic Agents; Apoptosis; Carbanilides; Cardiomyopathies; Cardiotonic Agents; Cell Line, Tumor; Doxorubicin; Heart; Humans; Khellin; Malate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Mitochondria; Muscle Contraction; Myocytes, Cardiac; Neoplasm Transplantation; Zebrafish	2014

Article

Year

Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.

Science translational medicine, 2014, Dec-10, Volume: 6, Issue:266

Topics: Animals; Antineoplastic Agents; Apoptosis; Carbanilides; Cardiomyopathies; Cardiotonic Agents; Cell Line, Tumor; Doxorubicin; Heart; Humans; Khellin; Malate Dehydrogenase; Male; Mice; Mice, Inbred C57BL; Mitochondria; Muscle Contraction; Myocytes, Cardiac; Neoplasm Transplantation; Zebrafish

2014